Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 10, 2007, Pages 1012-1019

  Nie, Ruqiong ^a   Xia, Rui ^b,e   Zhong, Xingwu ^c   Xia, Zhengyuan ^b,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e YANGTZE UNIVERSITY   (China)

Author keywords

15 F 2t isoprostane; Myocardial ischemia reperfusion; Salvia miltiorrhiza

Indexed keywords

CREATINE KINASE MB; ISOPROSTANE DERIVATIVE; PHENOL DERIVATIVE; SALVIA MILTIORRHIZA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DRUG EFFECT; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SALVIA MILTIORRHIZA; TREATMENT INDICATION;

ANIMALS; ANTIOXIDANTS; DINOPROST; DRUGS, CHINESE HERBAL; ENDOTHELIN-1; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGAN SIZE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 38049045493     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-092     Document Type: Article

References (34)

1. Becker, L.B., vanden Hoek, T.L., Shao, Z.H., Li, C.Q., and Schumacker, P.T. 1999. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 277: H2240-H2246.
2. Bolli, R., Jeroudi, M.O., Patel, B.S., Aruoma, O.I., Halliwell, B., Lai, E.K., et al. 1989. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ. Res. 65: 607-622.
3. Bolli, R., Triana, J.F., and Jeroudi, M.O. 1990. Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning." Circ. Res. 67: 332-343.
4. Calabresi, L., Rossoni, G., Gomaraschi, M., Sisto, F., Berti, F., and Franceschini, G. 2003. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ. Res. 92: 330-337. doi:10.1161/01.RES.0000054201.60308.1A.
5. Cao, C.M., Xia, Q., Zhang, X., Xu, W.H., Jiang, H.D., and Chen, J.Z. 2003. Salvia miltiorrhiza attenuates the changes in contraction and intracellular calcium induced by anoxia and reoxygenation in rat cardiomyocytes. Life Sci. 72: 2451-2463. doi:10.1016/S0024-3205(03)00142-5.
6. Chocron, S., Alwan, K., Toubin, G., Kantelip, B., Clement, F., Kantelip, J.P., et al. 1996. Effects of myocardial ischemia on the release of cardiac troponin I in isolated rat hearts. J. Thorac. Cardiovasc. Surg. 112: 508-513. doi:10.1016/S0022-5223(96)70279-9.
7. Das, D.K., and Maulik, N. 2006. Cardiac genomic response following preconditioning stimulus. Cardiovasc. Res. 70: 254-263. doi:10.1016/j.cardiores.2006.02.023.
8. Duda, M., Konior, A., Klemenska, E., and Beresewicz, A. 2007. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart. J. Mol. Cell. Cardiol. 42: 400-410. doi:10.1016/j.yjmcc.2006.10.014.
9. Ebel, D., Schlack, W., Comfere, T., Preckel, B., and Thamer, V. 1999. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br. J. Anaesth. 83: 903-908.
10. Fung, K.P., Zeng, L.H., Wu, J., Wong, H.N., Lee, C.M., Hon, P.M., et al. 1993. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci. 52: PL239-PL244. doi:10.1016/0024-3205(93)90471-E.
11. Kevin, L.G., Novalija, E., and Stowe, D.F. 2005. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth. Analg. 101: 1275-1287. doi:10.1213/01.ANE.0000180999. 81013.D0.
12. Kokita, N., and Hara, A. 1996. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology, 84: 117-127. doi:10.1097/00000542-199601000-00014.
13. Lam, F.F., Yeung, J.H., Chan, K.M., and Or, P.M. 2007. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vascul. Pharmacol. 46: 271-277. doi:10.1016/j.vph.2006.10.011.
14. Liu, G.T., Zhang, T.M., Wang, B.E., and Wang, Y.W. 1992. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem. Pharmacol. 43: 147-152. doi:10.1016/0006-2952(92) 90271-J.
15. Lopez-Ongil, S., Senchak, V., Saura, M., Zaragoza, C., Ames, M., Ballermann, B., et al. 2000. Superoxide regulation of endothelin-converting enzyme. J. Biol. Chem. 275: 26423-26427. doi:10.1074/jbc.M000767200.
16. Mehlhorn, U., Krahwinkel, A., Geissler, H.J., LaRosee, K., Fischer, U.M., Klass, O., et al. 2003. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J. Thorac. Cardiovasc. Surg. 125: 178-183. doi:10.1067/mtc.2003.97.
17. Morrow, J.D., and Roberts, L.J. 1997. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36: 1-21. doi:10.1016/S0163-7827(97)00001-5.
18. Murry, C.E., Jennings, R.B., and Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74: 1124-1136.
19. Neuzil, J., Rayner, B.S., Lowe, H.C., and Witting, P.K. 2005. Oxidative stress in myocardial ischaemia reperfusion injury: a renewed focus on a long-standing area of heart research. Redox Rep. 10: 187-197. doi:10.1179/135100005X57391.
20. Pagliaro, P., Gattullo, D., Rastaldo, R., and Losano, G. 2001. Ischemic preconditioning: from the first to the second window of protection. Life Sci. 69: 1-15. doi:10.1016/S0024-3205(01)01113-4.
21. Piper, H.M., Abdallah, Y., and Schafer, C 2004. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc. Res. 61: 365-371. doi:10.1016/j.cardiores.2003.12.012.
22. Qin, Q., Yang, X.M., Cui, L., Critz, S.D., Cohen, M.V., Browner, N.C., et al. 2004. Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 287: H712-H718. doi:10.1152/ajpheart.00954.2003.
23. Ross, S., Munoz, H., Piriou, V., Ryder, W.A., and Foex, P. 1998. A comparison of the effects of fentanyl and propofol on left ventricular contractility during myocardial stunning. Acta Anaesthesiol. Scand. 42: 23-31.
24. Scarabelli, T., Stephanou, A., Rayment, N., Pasini, E., Comini, L., Curello, S., et al. 2001. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation, 104: 253-256.
25. Ulus, A.T., Aksoyek, A., Ozkan, M., Katircioglu, S.F., and Basu, S. 2003. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic. Biol. Med. 34: 911-917. doi:10.1016/S0891-5849(03)00030-3.
26. Wang, Y., and Wang, D.H. 2004. Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am. J. Physiol. Heart Circ. Physiol. 287: H1868-H1874. doi:10.1152/ajpheart.00241.2004.
27. Wu, T.W., Zeng, L.H., Fung, K.P., Wu, J., Pang, H., Grey, A.A., et al. 1993. Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem. Pharmacol. 46: 2327-2332. doi:10.1016/0006-2952(93)90624-6.
28. Xia, Z., Godin, D.V., and Ansley, D.M. 2003a. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc. Res. 59: 113-121. doi:10.1016/S0008-6363(03)00351-1.
29. Xia, Z., Godin, D.V., Chang, T.K., and Ansley, D.M. 20036. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can. J. Physiol. Pharmacol. 81: 14-21. doi:10.1139/y02-170.
30. Xia, Z., Godin, D.V., and Ansley, D.M. 2004. Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity. Can. J. Physiol. Pharmacol. 82: 919-926. doi:10.1139/y04-097.
31. Xia, Z., Kuo, K.H., Godin, D.V., Walker, M.J., Tao, M.C., and Ansley, D.M. 2005. 15-F(2t)-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts. Am. J. Physiol. Heart Circ. Physiol. 289: H1366-H1372. doi:10.1152/ajpheart.00042.2005.
32. Yagi, A., Fujimoto, K., Tanonaka, K., Hirai, K., and Takeo, S. 1989. Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements. Planta Med. 55: 51-54. doi:10.1055/s-2006-961824.
33. Zhou, W., and Ruigrok, T.J. 1990. Protective effect of danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am. J. Chin. Med. 18: 19-24. doi:10.1142/S0192415X90000046.
34. Zhou, L., Zuo, Z., and Chow, M.S. 2005. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45: 1345-1359. doi:10.1177/0091270005282630.